How BMS is Doing RBM (Risk-Based Monitoring)

May 14, 2014
Guest Blogger
Pharmaceutical Executive

At this year’s Bio IT World Conference, Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb,

At this year’s Bio IT World Conference, Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb, elaborated on BMS’s risk-based monitoring (RBM) pilot, and how they are leveraging data, statistical analysis and personnel to execute RBM.

In this Applied Clinical Trials blog, Moe Alsumidale outlines the BMS’s RBM infrastructure.